Ingenuity Blog
Your Molecule Has Met Its Match
Filter by:
Featured
Biomanufacturing Trends Shaping 2026
2026 is shaping up to be a year of steady progress for biopharmaceutical innovators. While development activity remains strong, sponsors are operating in a challenging environment characterized by increasingly complex modalities, lean resourcing, regulatory uncertainty, and heightened emphasis...
Loading...
Cytovance recently appeared on the Outsourced Pharma Large Molecule Capacity Update to share how our available capacity, US-based manufacturing, and...
This partnership provides the industry with an integrated solution for customers seeking to outsource cell line development through to cGMP...
Discover the role of Artificial Intelligence in revolutionizing biologics manufacturing and learn how Cytovance and partners at the University of...
This partnership provides the industry with cutting-edge options for mammalian-expressed products.OKLAHOMA CITY, Oklahoma, MONTHEY, Switzerland, May 8, 2024 – ExcellGene...
An efficient microbial strain development strategy stands as the cornerstone of expediting product development timelines and enhancing the overall product...
Harnessing the incredible power of microorganisms to produce a wide array of valuable compounds is as old as recorded civilization...
This best-of-breed partnership will expedite sterile injectables to patients through the optimized transfer of bulk drug substance to finished drug...
One of the most critical points in a drug’s journey to patients is the successful scaling up from R&D to...
This partnership will give the industry new, more efficient options for E. coli-expressed products across many indications of drug development....
OKLAHOMA CITY, Oklahoma, September 27, 2023 – Cytovance Biologics, a leading full-service mammalian and microbial large molecule contract development and...
Demand for outsourcing microbial manufacturing has increased dramatically in recent years and will doubtlessly continue as novel drugs are more...
Chinese Hamster Ovary (CHO) cells are considered the gold standard in the production of biologics. Shown here at 100x. ...
End of content
No more pages to load
